Device
BioFreedom
BioFreedom is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
1
25%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Other(2)
Detailed Status
unknown2
Completed1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (33.3%)
N/A2 (66.7%)
Trials by Status
unknown250%
completed125%
not_yet_recruiting125%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable
A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug-coated Stents and the Xience Drug-eluting Stent System in Patients With Acute Coronary Syndrome and High Bleeding Risk Using Optical Coherence Tomography
NCT07230847
unknownnot_applicable
The SORT OUT IX STEMI OCT Trial
NCT02915107
unknownphase_4
BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX
NCT02623140
completed
Outcome of CHAllenging lesioNs and Patients Treated With Polymer Free Drug-CoatEd Stent
NCT03622203
Clinical Trials (4)
Showing 4 of 4 trials
NCT07230847Not Applicable
A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug-coated Stents and the Xience Drug-eluting Stent System in Patients With Acute Coronary Syndrome and High Bleeding Risk Using Optical Coherence Tomography
NCT02915107Not Applicable
The SORT OUT IX STEMI OCT Trial
NCT02623140Phase 4
BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX
NCT03622203
Outcome of CHAllenging lesioNs and Patients Treated With Polymer Free Drug-CoatEd Stent
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4